Equity Analysis /
United States of America

US : Sarepta Therapeutics, Inc. - SRPT | Framing our Expectations for DMD Gene Therapy Study-102 Crossover Data (TBA on Mon Jan 10th)

    Danielle Brill
    CGS-CIMB
    7 January 2022
    Published by